After a kidney transplant, men’s heart pumping ability improves more than women’s, even though women’s hearts were already pumping better to start with.
Claim Context
In adults with chronic kidney disease undergoing kidney transplantation, men show greater improvement in left ventricular ejection fraction (EF) over six months compared to women, despite starting with lower baseline EF (54.54% vs. 64.47%), suggesting sex-specific recovery of systolic function.
“Ejection Fraction was lower in men than women at baseline, increased at 3 months, and remained stable at month 6. In women, EF did not change significantly during follow-up.”
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether testosterone suppression in men or estrogen augmentation in women alters EF recovery post-transplant.
A double-blind RCT of 180 transplant recipients (90 male, 90 female) randomized to receive either testosterone blocker (e.g., bicalutamide 50mg/day) or placebo in men, and estradiol (1mg/day) or placebo in women, for 6 months, with primary outcome of EF change via cardiac MRI.
Whether EF improvement post-transplant is independently associated with sex after adjusting for age, BP, and renal function.
A prospective cohort of 400 kidney transplant recipients (200 male, 200 female) followed for 24 months with serial EF measurements via echocardiography and adjustment for baseline LVH, hypertension, and eGFR.
Whether men with minimal EF improvement have higher testosterone or lower estrogen levels than those with marked improvement.
A case-control study comparing 40 men with <5% EF increase to 40 with >10% increase, matched for baseline EF and age, measuring serum testosterone and estradiol at 3 and 6 months post-transplant.
Whether EF at 6 months post-transplant correlates with sex hormone levels at that time point.
A cross-sectional analysis of 250 transplant recipients at 6 months post-transplant, measuring EF via echocardiography and serum estradiol/testosterone levels, adjusting for age, BMI, and renal function.
Whether rare endocrine disorders (e.g., hypogonadism or hyperestrogenism) alter EF recovery post-transplant.
A case series of 8 patients with documented sex hormone disorders undergoing kidney transplantation, with detailed serial echocardiographic and hormonal profiling.